Idexx Laboratories Inc. diskutieren
Idexx Laboratories Inc.
WKN: 888210 / Symbol: IDXX / Name: IDEXX Labs / Aktie / Ausrüstung & Versorgung / Large Cap /
599,80 €
-1,06 %
IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target lowered by analysts at JPMorgan Chase & Co. from $630.00 to $575.00. They now have an "overweight" rating on the stock.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target lowered by analysts at Barclays PLC from $570.00 to $481.00. They now have an "overweight" rating on the stock.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $500.00 price target on the stock.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target lowered by analysts at Morgan Stanley from $559.00 to $550.00. They now have an "overweight" rating on the stock.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target raised by analysts at Barclays PLC from $481.00 to $520.00. They now have an "overweight" rating on the stock.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target raised by analysts at Morgan Stanley from $548.00 to $558.00. They now have an "overweight" rating on the stock.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target raised by analysts at Leerink Partners from $515.00 to $580.00. They now have an "outperform" rating on the stock.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $625.00 price target on the stock.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target raised by analysts at Leerink Partners from $580.00 to $600.00. They now have an "outperform" rating on the stock.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target raised by analysts at BTIG Research from $545.00 to $785.00. They now have a "buy" rating on the stock.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target raised by analysts at Morgan Stanley from $722.00 to $765.00. They now have an "overweight" rating on the stock.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) had its price target raised by analysts at JPMorgan Chase & Co. from $675.00 to $775.00. They now have an "overweight" rating on the stock.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) was given a new $805.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Ratings data for IDXX provided by MarketBeat
Neueste Beiträge
Wells_Fargo___Compan in Johnson & Johnson diskutieren